Published in Vaccine Weekly, July 26th, 2006
Study 1: Investigators discuss the optimization of cancer immunotherapy trials in a recent issue of the European Journal of Immunology.
According to their article, "Attempts to raise effective immunity against cancer are benefiting from information on the nature of the immunity involved and its regulation and, perhaps, now it is time to step back and define our approach in molecular terms prior to clinical testing. Although there are immunological differences between mice and patients, results from murine studies are encouraging early...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly